Myriad Genetics to Release Fourth-Quarter Financial Results

Myriad Genetics to Release Fourth-Quarter Financial Results

SALT LAKE CITY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold......

menu
menu